1,500
Participants
Start Date
November 1, 2022
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2026
Generate synthetic multimodal (clinical, omics and imaging) data for rare haematological diseases with a validated clinical result
"O1. Provide novel methods and capabilities to generate synthetic multimodal clinical, omics and imaging data for SCD with a validated clinical result.~O2. Develop de-identification, minimisation and anonymisation pipelines, including automatic assessment of privacy levels, at the service of clinical research and care.~O3. Consolidate and scale-up the use of FL applications, SMPC and DP solutions for privacy-preserving local algorithm training and global model aggregation.~O4. Ensure ethical and GDPR compliance in anonymised and synthetic data-driven research in RHDs.~O5. Ensure wide uptake and scalability of the developed methodologies and tools through effective stakeholder engagement, dissemination and open science practices."
Azienda Ospedale Università Padova, Padua
UMC Utrecht, Utrecht
Vall Hebron Institut de Recerca, Barcelona
Collaborators (1)
Universidad Politecnica de Madrid
OTHER
Datawizard SRL
UNKNOWN
University of Southampton
OTHER
Humanitas Mirasole SpA
OTHER
Charite University, Berlin, Germany
OTHER
Universita degli Studi di Padova
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER
Vicomtech
UNKNOWN
GLSMED Learning Health S.A.
OTHER
UMC Utrecht
OTHER
Intrasoft
UNKNOWN
Hospital Universitari Vall d'Hebron Research Institute
OTHER